A retrospective study of thyroid function test abnormalities in patients receiving immune checkpoint inhibitor therapy for cancer
Latest Information Update: 10 Nov 2019
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 12 Jun 2017 New trial record
- 06 Jun 2017 Results (n=279) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology